Morgan Stanley’s Evaxion A/S EVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-69
Closed -$2.87K 7846
2023
Q3
$2.87K Hold
69
﹤0.01% 7043
2023
Q2
$4.51K Sell
69
-656
-90% -$45.8K ﹤0.01% 7009
2023
Q1
$40.9K Buy
725
+651
+880% +$47.2K ﹤0.01% 6353
2022
Q4
$6.56K Hold
74
﹤0.01% 7079
2022
Q3
$10K Sell
74
-12
-14% -$1.51K ﹤0.01% 7063
2022
Q2
$8K Sell
86
-81
-49% -$9.26K ﹤0.01% 7267
2022
Q1
$26K Buy
167
+93
+126% +$15.3K ﹤0.01% 7023
2021
Q4
$16K Buy
74
+70
+1,750% +$21.7K ﹤0.01% 7298
2021
Q3
$2K Buy
+4
New +$1.37K ﹤0.01% 7659
2021
Q2
Sell
-2
Closed -$1K 7758
2021
Q1
$1K Buy
+2
New +$765 ﹤0.01% 7342

Other funds holding EVAX

Morgan Stanley's EVAX Position: Q4 2023 in Review

Morgan Stanley sold out of Evaxion A/S (EVAX) in Q4 2023, closing a stake of 69 shares — an estimated $2.87K sold.

Morgan Stanley first reported a position in EVAX in Q1 2021 and held it in 10 quarters. The position peaked at $40.9K in Q1 2023. 9 funds tracked by Wall St. Rank hold EVAX as of Q4 2023.

  • Morgan Stanley reported no remaining Evaxion A/S position as of Q4 2023 after selling out during the quarter.
  • Morgan Stanley sold 69 Evaxion A/S shares in Q4 2023, an estimated $2.87K.
  • Morgan Stanley first reported a position in Evaxion A/S in Q1 2021 and held it in 10 quarters.
  • Morgan Stanley's Evaxion A/S position peaked at $40.9K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Evaxion A/S as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.